Search

This article explores the use of artificial intelligence (AI) in managing insulin therapy for patients with type 2 diabetes. It focuses on the d-Nav® technology, which allows for autonomous insulin titration in patients using insulin injections. The study evaluated the effectiveness of d-Nav® in maintaining glucose levels within the target range and found that users spent nearly 70% of the time in the target range. The article also includes a case study of a woman who has been using basal-bolus insulin therapy for 29 years and provides a table comparing different insulin regimens. This information may be valuable for library patrons researching diabetes management and insulin therapy. [Extracted from the article]